Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Am J Surg. 2010 Apr;199(4):542–548. doi: 10.1016/j.amjsurg.2009.11.002

Figure 6.

Figure 6

CsA inhibits pro-apoptotic BAK (BH3) peptide induced caspase-3 activity, in rat lung microvascular endothelial cells (RLMEC) whereas CIP treatment shows no significant effect. BAK (BH3) transfection significantly increased caspase-3 activity compared with control cells (*p < 0.05; n = 5). CsA pre-treatment in BAK (BH3) transfected cells shows significant decrease in caspase-3 activity compared with BAK (BH3) transfected cells without CsA pre-treatment or with CIP treated-BAK transfected cells (†p < 0.05; n = 5).